5Choi WW,Weisenburger DD,Greiner TC,et al.A new immunostain al- gorithm classifies diffuse large B-cell lymphoma into molecular sub- types with high accuracy[J].Clin Cancer Res,15(17):5494-5502.
6Tomita N.BCL2 and MYC double-hit lymphoma/leukemia[J].J Clin Exp Hematop,2011,51(1):7-12.
2de Larrinoa AF, del Cura J, Zabala R, et al. Value of ultrasound-guided core biopsy in the diagnosis of malignant lymphoma [J]. J Clin Ultrasound, 2007,35(6): 295-301.
3Vandervelde C, Kamani T, Varghese A, et al. A study to evaluate the efficacy of image-guided core biopsy in the diagnosis and management of lymphoma-results in 103 biopsies [J-. Eur J Radiol, 2008,66( 1 ): 107-111.
5NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin's lymphomas, http ://www.nccn.org/professionals/physician gls/ f_guidelines.asp#site.
6克小燕,高子芬.现代肿瘤临床诊治丛书[M]∥淋巴瘤.北京:科学技术文献出版社.2009.
7Stein H, CHAN JKC, Wamke RA, et al. World Heahh Organization Classification of Tumor of Haematopoietic and Lymphoid Tissues. France: IARC Press Lyon,2008: 233-244.
8Choi WW, Montes-Moreno S, Chan WC, et al. A new immunostain algorithm improves the classification of diffuse large B-cell lymphoma into prognositicaly significant subgroups. Clin Cancer Res, 2009,15 : 5494-5502.
9Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 2000, 403: 503-511.
10Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large- B-cell lymphoma. N Engl J Med, 2002,346: 1937-1946.
2Cheson BD, Homing SJ, Coiffier B,et al.Report of an in- ternational workshop to standardize response criteria for non-Hodgkin's lymphomas [ J].J Clin Oncol, 1999, 17 (4) : 1244-1253.
3Pasqualucci L,Dalla-Favera R.The Genetic Landscape of Diffuse Large B-Cell Lymphoma [ J ]. Semin Hematol, 2015,52(2) :67-76.
4Ha H, Keam B, Kim TM, et al. Reduced dose intensities of doxorubicin in elderly patients with DLBCL in rituximab era [ J ]. Cancer Res Treat, 2015, 10 ( 41 ) : 339-342.
5Tsai PC, Hernandez-Ilizaliturri FJ, Bangia N, et al. Regu- lation of CD20 in rituximab-resistant cell lines and b-cell non-hodgkin tymphoma [ J ]. Clin Cancer Res, 2012, 18 (4) : 1039-1050.
6Ulrich W, Riccardo AA. Diffuse large B-cell Non- Hodgkin' s lymphoma (DLBCL-NHL) [ M ]. London : Springer, 2015 : 185 -202.
7Molina A.A deeade of rituximab: improving survival out- comes in non-Hodgkin' s lymphoma[ J ].Annu Rev M ed, 2008,59(12) :237-250.
8Habermann TM, Weller EA, Morrison VA, et al.Rituximab- CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma[J].J Clin Oneol,2006,24(19) : 103.
9Cheson BD, Homing S J, Coiffier B, et al. Report of an international workshop to standardize response criteria for nonHodgkin's lymphomas[J]. J Clin Oncol, 1999, 17(4): 12441253.
10Pasqualucci L, Dalla-Favera R. The genetic landscape of diffuse large B-cell lymphoma[J]. Semin Hematol, 2015, 52 (2): 67-76.
